Bayer, Versant Mount New Stem-Cell Venture — WSJ – Nasdaq
|
Bayer, Versant Mount New Stem–Cell Venture — WSJ
Nasdaq FRANKFURT — German pharmaceuticals giant Bayer AG and U.S. health care investor Versant Ventures plan to establish a stem–cell research company, marking the latest effort by a big pharmaceutical company to develop new and innovative drugs by … Bayer investing in Toronto-based stem–cell research company |
